Alex M. Okyay Kilinc, Ph.D is a CEO at Morpheus Biolabs based in San Diego, California, United States, North America. CEO of Morpheus Biolabs, a CRO founded in San Diego that provides in vivo and in vitro pre-clinical services and platform-based studies to pharmaceutical companies, biotech, CRO partners, and small to midsize research and discovery organizations to assist with their experimental approaches in discovery and translational settings. Specialized is immunology, molecular biology, immuno-oncology, infection, inflammation, with more than 20 years of experience. Successful track record in designing workflows for validating discovery targets and setting up relevant in-vitro and in-vivo model systems. Proven expertise in leading teams to propose, validate, and advance targets with a commitment to scientific excellence, innovation, and strategic collaboration.Passionate about advancing breakthrough technologies. Author of more than 20 publications with over 900 citations.
Current Position: CEO
Company: Morpheus Biolabs
Location: San Diego, California, United States, North America
Social: Professional profiles available
Network: Extensive professional connections